REMAX
Price
$20.81
Change
+$0.11 (+0.53%)
Updated
Dec 26 closing price
Net Assets
1.15B
VEMIX
Price
$33.84
Change
-$0.02 (-0.06%)
Updated
Dec 24 closing price
Net Assets
141.2B
Interact to see
Advertisement

REMAX vs VEMIX

Header iconREMAX vs VEMIX Comparison
Open Charts REMAX vs VEMIXBanner chart's image
Russell Inv Emerging Markets A
Price$20.81
Change+$0.11 (+0.53%)
VolumeN/A
Net Assets1.15B
Vanguard Emerging Mkts Stock Idx Instl
Price$33.84
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets141.2B
REMAX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
REMAX vs. VEMIX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMAX is a Buy and VEMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 141B vs. REMAX (1.15B). VEMIX pays higher dividends than REMAX: VEMIX (2.82) vs REMAX (1.79). REMAX was incepted earlier than VEMIX: REMAX (19 years) vs VEMIX (26 years). REMAX (1.56) is less costly to investors than VEMIX (0.09). REMAX is a more actively managed with annual turnover of: 66.00 vs. VEMIX (8.00). REMAX has a lower initial minimum investment than VEMIX: REMAX (0) vs VEMIX (5000000). REMAX annual gain was more profitable for investors over the last year : 28.65 vs. VEMIX (20.22). VEMIX return over 5 years is better than : 20.62 vs. REMAX (6.38).
REMAXVEMIXREMAX / VEMIX
Total Expense Ratio1.440.091,600%
Annual Report Gross Expense Ratio1.560.091,733%
Fund Existence19 years26 years-
Gain YTD30.93021.721142%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B141B1%
Annual Yield % from dividends1.792.8264%
Returns for 1 year28.6520.22142%
Returns for 3 years52.4146.12114%
Returns for 5 years6.3820.6231%
Returns for 10 years55.4789.0362%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRSP56.710.25
+0.44%
CRISPR Therapeutics AG
FACT10.39N/A
N/A
Fact II Acquisition Corp
BOWN9.19N/A
N/A
Bowen Acquisition Corp
NU16.74-0.02
-0.12%
Nu Holdings Ltd
NEXA8.85-0.05
-0.56%
Nexa Resources SA